Abstract Quality Initiative (K/DOQI) Practice Guidelines for anemia and iron indices apply to
all patients with chronic kidney disease (CKD), regardless of dialysis dependence (National …

Ferumoxytol, a high-molecular-weight carbohydrate-iron complex, is indicated for the
intravenous treatment of iron deficiency anaemia in adults with chronic kidney disease. In …

Methods: This randomised controlled study was designed as a pilot study to compare the
efficacy and safety outcomes between a reactive protocol of intermittent bolus intravenous …

Discusses risks and benefits of the intravenous iron therapy. Increase in the number of
hemodialysis patients treated with iron dextran in 1997; Reduction in the prevalence of iron …

While oral iron can be used to manage iron stores in some hemodialysis patients, most
require intravenous iron supplementation. Maintenance of iron balance in these patients is …

Background Anaemia among haemodialysis patients is treated with iron and erythropoietin-
stimulating agents (ESAs). ESAs reduce requirements for blood transfusions but are also …

Background Although the efficacy of iron sucrose (IS) and ferric carboxymaltose (FCM) in
treating anemia in hemodialysis (HD) patients has been studied individually, a comparison …

The management of anemia in uremic patients undergoing hemodialysis requires the
appropriate combination of erythropoietin treatment, iron supplementation, and on occasion …

Abstract Both the Kidney Disease Outcomes Quality Initiative (KDOQI) Guidelines and the
European Best Practice Guidelines (EBPG) support the use of substantial doses of iron …

Background Controversy exists about any differences in longer-term safety across different
intravenous iron formulations routinely used in hemodialysis (HD) patients. We exploited a …